A topically applied compound best proven for calming facial redness, fading dark spots and uneven tone, and clearing blemishes. Support for smoother texture and brightness is moderate, while wrinkle and deep-structure claims remain unproven. Its safety record is strong, with mostly mild, temporary side effects. Affordable and widely available; consistent use and daily sun protection matter most. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Standardized facial photography | Progressive reduction in redness, pigment, and lesions vs. baseline | Objective visual tracking of the rejuvenation goal |
| Pigmentation severity | ≥50% lightening of target patches by 16 weeks | Quantifies melasma/pigment response |
| Inflammatory lesion count | ≥50% reduction by 8–12 weeks | Tracks anti-inflammatory response for rosacea/acne |
| Overall severity rating | "Clear" or "almost clear" | Captures global response beyond a single feature |
| Irritation/tolerability | Minimal or none after 2–4 weeks | Detects over-use before it forces discontinuation |
Cadence: Tolerability at 1–2 weeks; early response at 4 weeks; redness/lesions at 8–12 weeks; pigment/tone at 16–24 weeks; then every 3–6 months during maintenance